MRD / Regn No. : SG000771 Date : 19/06/2026
Patient Name : Rajni Bagla Age & Gender : 59 Yrs. / Female
Contact No. : 9831070686 UHID :
Ht / Wt / BMI : 154 / 72 / 30.36 BP S / BP D : 104 / 78
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (01/Jan/1970) | HYPERTENSION (02/Feb/2023) | MASLD (24/Apr/2025) |
Salient Investigations : CREATININE: 0.51 | EGFR EGLOMERULAR FILTRATION RATE: 132.10 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 118 mg/dL | HB HEMOGLOBIN: 10.7 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 7 % | LDL LOW DENSITY LIPOPROTEIN: 66 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 164 mg/dL | TSH THYROID STIMULATING HORMONE: 3.39 mIU/L
S# Generic (Trade) Name Route Dosage Usage Duration
1 TABLET TELMISARTAN 40 MG + ATORVASTATIN 10 MG
ARBITEL AV
Medicine For PO 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
2 ANTIHYPERGLYCEMIC SITAGLIPTIN 100 MG + DAPAGLIFLOZIN 10 MG + METFORMIN 1000 MG
LUPISIT DM 1000 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
3 ANTIHYPERGLYCEMIC GLICLAZIDE XR 60 MG
SECGLY XR 60 MG 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 19/Dec/2026
Tests Suggested For Next Visit : HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE,LFT WITH PLATELET COUNT
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: